Drugs such as Cobenfy could reshape the antipsychotic market, providing a more nuanced range of patient options.

As interest in psychedelic medicine grows, researchers have synthesized a decade of evidence to understand how ayahuasca ...

Neushen Therapeutics Inc. has synthesized 5-HT2A receptor agonists reported to be useful for the treatment of depression, schizophrenia, anxiety and post-traumatic stress disorder.

Explore ayahuasca's effects on anxiety, memory, and emotional processing, revealing its therapeutic potential for ...

The review synthesizes evidence showing that ayahuasca's effects involve a delicate balance between two serotonin receptor types: 5-HT2A and 5-HT1A. This dual action appears crucial for understanding ...

According to the partners, DSP-0038 combines serotonin 5-HT2A receptor antagonism and 5-HT1A receptor agonism – two well established targets for antipsychotic drugs – in a single small molecule.

SF is a 50-year-old woman, counseled about the therapeutic use of psilocybin by her neurologist, who has participated in ...

The Pacalis team is a blend of industry and academic expertise, led by co-founder and Monash university alumnus Dr David Bibby as Chief Executive Officer, and co-founder Professor Chris Langmead, ...

Longboard Pharmaceuticals has commenced the Phase III DEEp OCEAN Study of its investigational oral drug bexicaserin for ...

such as 5-HT2A, alpha1 adrenergic, and H1 histamine receptors. This effect may be one of the main reasons trazodone works as a sleep aid. Keep reading to learn more about what to consider before ...